25 results on '"Mast, Hetty"'
Search Results
2. Quality of Life of Oligometastatic and Polymetastatic Head and Neck Squamous Cell Carcinoma Patients
- Author
-
Berzenji, Diako, Dorr, Maarten C., Sewnaik, Aniel, Mast, Hetty, Offerman, Marinella P.J., Baatenburg de Jong, Robert J., Hardillo, Jose A., Berzenji, Diako, Dorr, Maarten C., Sewnaik, Aniel, Mast, Hetty, Offerman, Marinella P.J., Baatenburg de Jong, Robert J., and Hardillo, Jose A.
- Abstract
Objective: Evidence suggests that distant metastasis in head and neck squamous cell carcinoma is a spectrum of disease. Previous studies show that oligometastasis has favorable survival compared with polymetastasis. The quality of life of patients with oligometastasis remains unknown. To further solidify the position of oligometastasis as a separate entity, we hypothesized that oligometastatic patients experience better quality of life than polymetastatic patients.Methods: Patients with distant metastasis were stratified into three groups: oligometastasis (≤3 metastatic foci in ≤2 anatomic sites), explosive metastasis (≥4 metastatic foci at one anatomic site), and explosive-disseminating metastasis (spread to ≥3 anatomic sites). Quality of life was assessed every 2 months post distant metastasis diagnosis. Results: Between January 1, 2016, and December 31, 2021, a total of 161 patients with distant metastasis were identified, with a total of 397 measurements. In this group, 57 (35.4%) patients had oligometastasis, 35 (21.7%) patients had explosive metastasis, and 69 (42.9%) patients had explosive-disseminating metastasis. Their median post-distant metastasis survivals were 8.5 months, 3.2 months, and 3.2 months respectively (p < 0.001). A significantly better overall quality of life was observed in the oligometastasis group compared with the polymetastatic groups (+0.75 out of 7, p < 0.05). Furthermore, oligometastatic patients performed better in the subdomains of “physical functioning,” “fatigue,” and “pain.”. Conclusion: Results from this study underscore that subgroups exist regarding quality of life and survival within distant metastasis, with polymetastatic patients performing worse than oligometastatic patients. This highlights the significance of tailored interventions that consider the unique challenges faced by each metastatic group of patients. Level of Evidence: 3, retr
- Published
- 2024
3. Personalizing dental screening and prevention protocols in dentulous patients with oropharyngeal cancer undergoing radiotherapy:A retrospective cohort study
- Author
-
Chin, Denzel, Mast, Hetty, Verduijn, Gerda M., Möring, Michelle, Petit, Steven F., Rozema, Frederik R., Wolvius, Eppo B., Jonker, Brend P., Heemsbergen, Wilma D., Chin, Denzel, Mast, Hetty, Verduijn, Gerda M., Möring, Michelle, Petit, Steven F., Rozema, Frederik R., Wolvius, Eppo B., Jonker, Brend P., and Heemsbergen, Wilma D.
- Abstract
Objectives:Patients with head and neck cancer are routinely screened for dental foci prior to radiotherapy (RT) to prevent post- RT tooth extractions associated with an increased risk of osteoradionecrosis. We evaluated the risk factors for post-RT tooth extraction to personalise dental screening and prevention protocols prior to RT. Materials and methods: This retrospective cohort study included dentulous patients diagnosed with oropharyngeal cancer who had undergone radiation therapy at doses 60–70 Gy and achieved a disease-free survival of ≥ 1 year (N = 174). Risk factors were assessed using Cox regression models. Results: The cumulative incidence of post-RT tooth extraction was 30.7 % at 5 years. Main indications for extraction (n = 62) were radiation caries (n = 20) and periodontal disease (n = 27). Risk factors associated (p < 0.05) with radiation caries-related extractions included active smoking, alcohol abuse, poor oral hygiene, parotid gland irradiation, and mandibular irradiation. A high-dose volume in the mandible was associated with periodontal disease events. Conclusion: Post-RT extractions due to radiation caries were influenced by lifestyle factors and RT dose in the mandible and parotid glands. Periodontal disease-related extractions were primarily associated with the mandibular dose. During dental screening these post-RT risk factors should be taken into account to prevent osteoradionecrosis.
- Published
- 2024
4. Endoscopic screening of the upper gastrointestinal tract for second primary tumors in patients with head and neck cancer in a Western country
- Author
-
Van Tilburg, Laurelle, Van De Ven, Steffi Elisabeth Maria, De Jonge, Pieter J.F., De Graaf, Wilmar, Spaander, Manon C.W., Nikkessen, Suzan, Hardillo, José, Sewnaik, Aniel, Monserez, Dominiek A., Mast, Hetty, Keereweer, Stijn, Bruno, Marco J., Baatenburg De Jong, Robert J., Koch, Arjun Dave, Van Tilburg, Laurelle, Van De Ven, Steffi Elisabeth Maria, De Jonge, Pieter J.F., De Graaf, Wilmar, Spaander, Manon C.W., Nikkessen, Suzan, Hardillo, José, Sewnaik, Aniel, Monserez, Dominiek A., Mast, Hetty, Keereweer, Stijn, Bruno, Marco J., Baatenburg De Jong, Robert J., and Koch, Arjun Dave
- Abstract
Background: Patients with head and neck squamous cell carcinoma (HNSCC) relatively frequent develop second primary tumors (SPTs) in the esophagus. Endoscopic screening could lead to timely detection of SPTs in early stages and therefore improves the survival. Methods: We performed a prospective endoscopic screening study in patients with HNSCC in a Western country. Patients with curably treated HNSCC diagnosed January 2017 to July 2021 were included. Routine imaging for HNSCC consisted of flexible transnasal endoscopy with PET/CT or MRI-scan, depending on primary HNSCC location. Screening was performed synchronously(<6 months) or metachronously (≥6 months) after HNSCC diagnosis. The primary outcome was prevalence of SPTs, defined as presence of esophageal high-grade dysplasia or squamous cell carcinoma. Results: We included 202 patients (81% male, mean age 65 years) and performed 250 screening endoscopies. HNSCC was located in the oropharynx(32%), hypopharynx(26%), larynx(22%), and oral cavity(19%). Endoscopic screening was performed within 6 months(34%), 6 months to 1 year(8%), 1 to 2 years(34%), and 2 to 5 years(24%) after HNSCC diagnosis. We detected 11 SPTs in 10 patients(5.0%, 95%CI: 2.4-8.9%) during synchronous(6/85) and metachronous screening(5/165). Most SPTs were detected in early stages(91%) and treated with curative intent with endoscopic resection(80%). No SPTs in screened patients were detected with routine imaging for HNSCC before endoscopic screening. Conclusion: In 5% of patients with HNSCC, an SPT was detected with endoscopic screening. Endoscopic screening should be considered in a selection of HNSCC patients to detect early-stage SPTs, based on highest SPT-risk and life expectancy depending on HNSCC and comorbidities.
- Published
- 2023
5. Long-term outcomes, quality of life, and costs of treatment modalities for T1–T2 lip carcinomas
- Author
-
van Hof, Kira S., Wakkee, Marlies, Sewnaik, Aniel, Herkendaal, Aimée F., Tans, Lisa, Mast, Hetty, van den Bos, Renate R., Mureau, Marc A.M., Offerman, Marinella P.J., Baatenburg de Jong, Robert J., van Hof, Kira S., Wakkee, Marlies, Sewnaik, Aniel, Herkendaal, Aimée F., Tans, Lisa, Mast, Hetty, van den Bos, Renate R., Mureau, Marc A.M., Offerman, Marinella P.J., and Baatenburg de Jong, Robert J.
- Abstract
Purpose: Early stage lip squamous cell carcinoma (lip SCC) can be treated with conventional excision, Mohs micrographic surgery (MMS), or brachytherapy. The aim of this retrospective study was to describe the medical outcomes, patient-reported outcomes, and costs of these treatments. Methods: A retrospective cohort study of T1–T2 lip SSCs treated between 1996 and 2019. Medical outcomes, recurrences, and survival were retrieved from medical records. Facial appearance, facial function, and Quality of Life (QoL) were measured with the Face-Q H&N and EQ-5D-5L questionnaires. Costs were also calculated. Results: Of the 336 lip SCCs, 122 were treated with excision, 139 with MMS, and 75 with brachytherapy. Locally, the recurrence rate was 2.7% and regionally 4.8%. There were 2% disease-related deaths. T2-stage and poor tumor differentiation were associated with recurrences. Posttreatment QoL, facial function, and appearance were rated as good. Brachytherapy was the most expensive treatment modality. Conclusion: Early-stage lip SCC has a good prognosis, with a disease-specific survival of 98.2% after a median follow-up of 36 months, there was a high QoL and satisfaction at long-term follow-up. Based on the costs and the risk of locoregional recurrences, we believe that, for most noncomplex lip SCCs, MMS would be the most logical treatment option.
- Published
- 2023
6. Development of a local dose-response relationship for osteoradionecrosis within the mandible
- Author
-
Sijtsema, Nienke D., Verduijn, Gerda M., Nasserinejad, Kazem, van Norden, Yvette, Mast, Hetty, van der Lugt, Aad, Hoogeman, Mischa S., Petit, Steven F., Sijtsema, Nienke D., Verduijn, Gerda M., Nasserinejad, Kazem, van Norden, Yvette, Mast, Hetty, van der Lugt, Aad, Hoogeman, Mischa S., and Petit, Steven F.
- Abstract
Purpose: Osteoradionecrosis (ORN) of the mandible is a severe complication following radiotherapy of the head and neck, but not all regions of the mandible may be equally at risk. Therefore our goal was to explore a local dose response relationship for subregions of the mandible. Materials and methods: All oropharyngeal cancer patients treated at our hospital between 2009 and 2016 were reviewed. Follow-up was cut-off at 3 years. For patients that developed ORN, the ORN volume was delineated on the planning CT. Each mandible was divided into 16 volumes of interest (VOIs) based on the location of the dental elements and the presence of ORN in each was scored. Generalized estimating equations were used to build a model for the probability of developing ORN in an element VOI. Results: Of the 219 included patients, 22 developed ORN in 89 element VOIs. Mean dose to the element VOI (odds ratio (OR) = 1.05 per Gy, 95% confidence interval (CI): (1.04,1.07)), pre-radiotherapy extractions of an element ipsilateral to element of interest (OR = 2.81, 95% CI: (1.12,7.05)), and smoking at start of radiotherapy (OR = 3.37, 95% CI: (1.29,8.78)) were significantly associated with an increased probability of ORN in the VOI. Conclusion: The developed dose-response model indicates that the probability of ORN varies within the mandible and strongly depends on the local dose, the location of extractions, and smoking.
- Published
- 2023
7. Ex Vivo Functional Assay for Evaluating Treatment Response in Tumor Tissue of Head and Neck Squamous Cell Carcinoma
- Author
-
Capala, Marta E., Pachler, Katrin S., Lauwers, Iris, de Korte, Maarten A., Verkaik, Nicole S., Mast, Hetty, Jonker, Brend P., Sewnaik, Aniel, Hardillo, Jose A., Keereweer, Stijn, Monserez, Dominiek, Koljenovic, Senada, Mostert, Bianca, Verduijn, Gerda M., Petit, Steven, van Gent, Dik C., Capala, Marta E., Pachler, Katrin S., Lauwers, Iris, de Korte, Maarten A., Verkaik, Nicole S., Mast, Hetty, Jonker, Brend P., Sewnaik, Aniel, Hardillo, Jose A., Keereweer, Stijn, Monserez, Dominiek, Koljenovic, Senada, Mostert, Bianca, Verduijn, Gerda M., Petit, Steven, and van Gent, Dik C.
- Abstract
Background: Head and neck squamous cell carcinoma (HNSCC) displays a large heterogeneity in treatment response, and consequently in patient prognosis. Despite extensive efforts, no clinically validated model is available to predict tumor response. Here we describe a functional test for predicting tumor response to radiation and chemotherapy on the level of the individual patient. Methods: Resection material of 17 primary HNSCC patients was cultured ex vivo, irradiated or cisplatin-treated, after which the effect on tumor cell vitality was analyzed several days after treatment. Results: Ionizing radiation (IR) affected tumor cell growth and viability with a clear dose-response relationship, and marked heterogeneity between tumors was observed. After a single dose of 5Gy, proliferation in IR-sensitive tumors dropped below 30% of the untreated level, while IR-resistant tumors maintained at least 60% of proliferation. IR-sensitive tumors showed on average a twofold increase in apoptosis, as well as an increased number and size of DNA damage foci after treatment. No differences in the homologous recombination (HR) proficiency between IR-sensitive and –resistant tumors were detected. Cisplatin caused a decrease in proliferation, as well as induction of apoptosis, again with marked variation between the samples. Conclusions: Our functional ex vivo assay discriminated between IR-sensitive and IR-resistant HNSCC tumors, and may also be suitable for predicting response to cisplatin. Its predictive value is currently under investigation in a prospective clinical study.
- Published
- 2023
8. Post radiation mucosal ulcer risk after a hypofractionated stereotactic boost and conventional fractionated radiotherapy for oropharyngeal carcinoma
- Author
-
Verduijn, Gerda M., Petit, Steven F., Lauwers, Iris, van Norden, Yvette, Sijtsema, Nienke D., Sewnaik, Aniel, Mast, Hetty, Capala, Marta, Nout, Remi, Baker, Sarah, van Meerten, Esther, Hoogeman, Mischa S., van der Lugt, Aad, Heemsbergen, Wilma D., Verduijn, Gerda M., Petit, Steven F., Lauwers, Iris, van Norden, Yvette, Sijtsema, Nienke D., Sewnaik, Aniel, Mast, Hetty, Capala, Marta, Nout, Remi, Baker, Sarah, van Meerten, Esther, Hoogeman, Mischa S., van der Lugt, Aad, and Heemsbergen, Wilma D.
- Abstract
Background/purpose: Post radiation mucosal ulcers (PRMU) after treatment for oropharyngeal squamous cell carcinoma (OPSCC) can have a huge negative impact on patients’ quality of life, but little is known concerning risk factors and the impact of fraction size. Therefore, the goal of this study was to determine the pattern of PRMU development and to identify risk factors after a hypofractionated stereotactic body radiotherapy boost (SBRT) compared to conventionally fractionated radiotherapy for OPSCC. Material and methods: We performed a retrospective cohort study (N = 332) of OPSCC patients with ≥ 1-year disease-free survival, treated with 46 Gy Intensity Modulated Radiotherapy (IMRT) (2 Gy fractions) followed by either an SBRT boost of 16.5 Gy (5.5 Gy fractions) (N = 180), or 24 Gy IMRT (2 Gy fractions) (N = 152). PRMU (grade ≥ 2) was scored when observed > three months after the last radiotherapy (RT) fraction (CTCAE v5.0). Potential risk factors were analyzed with Cox regression models using death as competing risk. Dose at the PRMU site was calculated by projecting delineated PRMU on the planning CT. Results: All cases of PRMU (N = 64) occurred within 24 months; all were grade 2. The cumulative incidence at 2 years in the SBRT boost group was 26% (N = 46) vs. 12% (N = 18) for conventional fractionation (p = 0.003). Most PRMU developed within nine months (N = 48). PRMU occurring > nine months (N = 16) were mainly observed in the SBRT boost group (N = 15). Sex (p = 0.048), acute tube feeding (p = < 0.001), tumor subsite tonsil (p = 0.001), and N stage (p = 0.017) were associated with PRMU risk at multivariable regression in the hypofractionated SBRT boost group. All 25 delineated PRMU were located within the high dose regions. Conclusion: The risk of PRMU should be included in the cost benefit analysis when considering future research using a hypofractionated SBRT boost for OPSCC patients.
- Published
- 2023
9. Ex Vivo Functional Assay for Evaluating Treatment Response in Tumor Tissue of Head and Neck Squamous Cell Carcinoma
- Author
-
Capala, Marta E., primary, Pachler, Katrin S., additional, Lauwers, Iris, additional, de Korte, Maarten A., additional, Verkaik, Nicole S., additional, Mast, Hetty, additional, Jonker, Brend P., additional, Sewnaik, Aniel, additional, Hardillo, Jose A., additional, Keereweer, Stijn, additional, Monserez, Dominiek, additional, Koljenovic, Senada, additional, Mostert, Bianca, additional, Verduijn, Gerda M., additional, Petit, Steven, additional, and van Gent, Dik C., additional
- Published
- 2023
- Full Text
- View/download PDF
10. The COMPLETE trial: HolistiC early respOnse assessMent for oroPharyngeaL cancEr paTiEnts; Protocol for an observational study
- Author
-
Verduijn, Gerda M, primary, Capala, Marta E, additional, Sijtsema, Nienke D, additional, Lauwers, Iris, additional, Hernandez Tamames, Juan A, additional, Heemsbergen, Wilma D, additional, Sewnaik, Aniel, additional, Hardillo, Jose A, additional, Mast, Hetty, additional, van Norden, Yvette, additional, Jansen, Maurice P H M, additional, van der Lugt, Aad, additional, van Gent, Dik C, additional, Hoogeman, Mischa S, additional, Mostert, Bianca, additional, and Petit, Steven F, additional
- Published
- 2022
- Full Text
- View/download PDF
11. Osteoradionecrosis after postoperative radiotherapy for oral cavity cancer:A retrospective cohort study
- Author
-
Möring, Michelle M., Mast, Hetty, Wolvius, Eppo B., Verduijn, Gerda M., Petit, Steven F., Sijtsema, Nienke D., Jonker, Brend P., Nout, Remi A., Heemsbergen, Wilma D., Möring, Michelle M., Mast, Hetty, Wolvius, Eppo B., Verduijn, Gerda M., Petit, Steven F., Sijtsema, Nienke D., Jonker, Brend P., Nout, Remi A., and Heemsbergen, Wilma D.
- Abstract
Objective: Osteoradionecrosis (ORN) is a severe late complication after radiotherapy but current knowledge on ORN risks in the setting of postoperative radiotherapy (PORT) is limited. We studied the incidence and risk factors of ORN in patients with oral cavity cancers (OCC, treated with PORT.Patients and Methods: A retrospective cohort study was conducted including OCC patients (mainly squamous cell) treated with postoperative intensity modulated radiotherapy between 2010 and 2018 with > 1 year disease-free survival. Cumulative incidences of ORN were computed using the Kaplan Meier method. Clinical and dosimetric risk factors for mandibular ORN were evaluated using Cox regression models.Results: Within our cohort (N = 227, median follow-up 49 months) we observed 46 cases of ORN, mainly in the mandible (n = 41). The cumulative incidence of mandibular ORN was 15.9 % (SE 2.5 %) at three years and 19.8 % (SE 3.0 %) at five years. At univariable analysis, smoking, mandibular mandibulotomy or segment resection, mean dose to the mandible, and mandible volume (%) >= 60 Gy (V60) were significantly associated with increased ORN risks. At multivariable analysis, smoking (HR 2.13, 95 %CI 1.12-4.06) and V60 (HR 1.02 per 1 % increase, 95 %CI 1.01-1.04) remained predictive factors. For active smokers with a high V60 >= 40 % we observed rapid ORN development with a 1-year incidence of 29 % vs 6 % for others (p < 0.01).Conclusion: OCC Patients treated with PORT are at high risk for mandibular ORN. We identified the mandibular volume receiving >= 60 Gy as the dominant risk factor, especially in active smokers. Limiting high-dose volumes at treatment planning may decrease ORN risks.
- Published
- 2022
12. The COMPLETE trial:HolistiC early respOnse assessMent for oroPharyngeaL cancEr paTiEnts; Protocol for an observational study
- Author
-
Verduijn, Gerda M., Capala, Marta E., Sijtsema, Nienke D., Lauwers, Iris, Hernandez Tamames, Juan A., Heemsbergen, Wilma D., Sewnaik, Aniel, Hardillo, Jose A., Mast, Hetty, Van Norden, Yvette, Jansen, Maurice P.H.M., Van Der Lugt, Aad, Van Gent, Dik C., Hoogeman, Mischa S., Mostert, Bianca, Petit, Steven F., Verduijn, Gerda M., Capala, Marta E., Sijtsema, Nienke D., Lauwers, Iris, Hernandez Tamames, Juan A., Heemsbergen, Wilma D., Sewnaik, Aniel, Hardillo, Jose A., Mast, Hetty, Van Norden, Yvette, Jansen, Maurice P.H.M., Van Der Lugt, Aad, Van Gent, Dik C., Hoogeman, Mischa S., Mostert, Bianca, and Petit, Steven F.
- Abstract
Introduction The locoregional failure (LRF) rate in human papilloma virus (HPV)-negative oropharyngeal squamous cell carcinoma (OPSCC) remains disappointingly high and toxicity is substantial. Response prediction prior to or early during treatment would provide opportunities for personalised treatment. Currently, there are no accurate predictive models available for correct OPSCC patient selection. Apparently, the pivotal driving forces that determine how a OPSCC responds to treatment, have yet to be elucidated. Therefore, the holistiC early respOnse assessMent for oroPharyngeaL cancer paTiEnts study focuses on a holistic approach to gain insight in novel potential prognostic biomarkers, acquired before and early during treatment, to predict response to treatment in HPV-negative patients with OPSCC. Methods and analysis This single-centre prospective observational study investigates 60 HPV-negative patients with OPSCC scheduled for primary radiotherapy (RT) with cisplatin or cetuximab, according to current clinical practice. A holistic approach will be used that aims to map the macroscopic (with Intra Voxel Incoherent Motion Diffusion Kurtosis Imaging (IVIM-DKI); before, during, and 3 months after RT), microscopic (with biopsies of the primary tumour acquired before treatment and irradiated ex vivo to assess radiosensitivity), and molecular landscape (with circulating tumour DNA (ctDNA) analysed before, during and 3 months after treatment). The main end point is locoregional control (LRC) 2 years after treatment. The primary objective is to determine whether a relative change in the mean of the diffusion coefficient D (an IVIM-DKI parameter) in the primary tumour early during treatment, improves the performance of a predictive model consisting of tumour volume only, for 2 years LRC after treatment. The secondary objectives investigate the potential of other IVIM-DKI parameters, ex vivo sensitivity characteristics, ctDNA, and combinations thereof as potential nove
- Published
- 2022
13. Malignant transformation of salivary gland pleomorphic adenoma: proof of principle
- Author
-
Valstar, Matthijs H, primary, Mast, Hetty, additional, Hove, Ivo, additional, Moonen, Laura R, additional, Balm, Alfons JM, additional, Smeele, Ludi E, additional, Koljenović, Senada, additional, Dinjens, Winand NM, additional, and Velthuysen, Marie‐Louise F, additional
- Published
- 2021
- Full Text
- View/download PDF
14. Intraoperative assessment of resection margins in oral cavity cancer:This is the way
- Author
-
Aaboubout, Yassine, Barroso, Elisa M., Algoe, Mahesh, Ewing-Graham, Patricia C., Hove, Ivo Ten, Mast, Hetty, Hardillo, José A., Sewnaik, Aniel, Monserez, Dominiek A., Keereweer, Stijn, Jonker, Brend P., van Lanschot, Cornelia G.F., Smits, Roeland W.H., Nunes Soares, Maria R., Ottevanger, Lars, Matlung, Sanne E., Seegers, Paul A., Dis, Vera van, Verdijk, Robert M., Wolvius, Eppo B., Caspers, Peter J., Bakker Schut, Tom C., Baatenburg de Jong, Robert J., Puppels, Gerwin J., Koljenović, Senada, Aaboubout, Yassine, Barroso, Elisa M., Algoe, Mahesh, Ewing-Graham, Patricia C., Hove, Ivo Ten, Mast, Hetty, Hardillo, José A., Sewnaik, Aniel, Monserez, Dominiek A., Keereweer, Stijn, Jonker, Brend P., van Lanschot, Cornelia G.F., Smits, Roeland W.H., Nunes Soares, Maria R., Ottevanger, Lars, Matlung, Sanne E., Seegers, Paul A., Dis, Vera van, Verdijk, Robert M., Wolvius, Eppo B., Caspers, Peter J., Bakker Schut, Tom C., Baatenburg de Jong, Robert J., Puppels, Gerwin J., and Koljenović, Senada
- Abstract
The goal of head and neck oncological surgery is complete tumor resection with adequate resection margins while preserving acceptable function and appearance. For oral cavity squamous cell carcinoma (OCSCC), different studies showed that only 15%-26% of all resections are adequate. A major reason for the low number of adequate resections is the lack of information during surgery; the margin status is only available after the final histopathologic assessment, days after surgery. The surgeons and pathologists at the Erasmus MC University Medical Center in Rotterdam started the implementation of specimen-driven intraoperative assessment of resection margins (IOARM) in 2013, which became the standard of care in 2015. This method enables the surgeon to turn an inadequate resection into an adequate resection by performing an additional resection during the initial surgery. Intraoperative assessment is supported by a relocation method procedure that allows accurate identification of inadequate margins (found on the specimen) in the wound bed. The implementation of this protocol resulted in an improvement of adequate resections from 15%-40%. However, the specimen-driven IOARM is not widely adopted because grossing fresh tissue is counter-intuitive for pathologists. The fear exists that grossing fresh tissue will deteriorate the anatomical orientation, shape, and size of the specimen and therefore will affect the final histopathologic assessment. These possible negative effects are countered by the described protocol. Here, the protocol for specimen-driven IOARM is presented in detail, as performed at the institute.
- Published
- 2021
15. Performance of Intraoperative Assessment of Resection Margins in Oral Cancer Surgery:A Review of Literature
- Author
-
Barroso, Elisa M., Aaboubout, Yassine, van der Sar, Lisette C., Mast, Hetty, Sewnaik, Aniel, Hardillo, Jose A., ten Hove, Ivo, Nunes Soares, Maria R., Ottevanger, Lars, Bakker Schut, Tom C., Puppels, Gerwin J., Koljenović, Senada, Barroso, Elisa M., Aaboubout, Yassine, van der Sar, Lisette C., Mast, Hetty, Sewnaik, Aniel, Hardillo, Jose A., ten Hove, Ivo, Nunes Soares, Maria R., Ottevanger, Lars, Bakker Schut, Tom C., Puppels, Gerwin J., and Koljenović, Senada
- Abstract
Introduction: Achieving adequate resection margins during oral cancer surgery is important to improve patient prognosis. Surgeons have the delicate task of achieving an adequate resection and safeguarding satisfactory remaining function and acceptable physical appearance, while relying on visual inspection, palpation, and preoperative imaging. Intraoperative assessment of resection margins (IOARM) is a multidisciplinary effort, which can guide towards adequate resections. Different forms of IOARM are currently used, but it is unknown how accurate these methods are in predicting margin status. Therefore, this review aims to investigate: 1) the IOARM methods currently used during oral cancer surgery, 2) their performance, and 3) their clinical relevance. Methods: A literature search was performed in the following databases: Embase, Medline, Web of Science Core Collection, Cochrane Central Register of Controlled Trials, and Google Scholar (from inception to January 23, 2020). IOARM performance was assessed in terms of accuracy, sensitivity, and specificity in predicting margin status, and the reduction of inadequate margins. Clinical relevance (i.e., overall survival, local recurrence, regional recurrence, local recurrence-free survival, disease-specific survival, adjuvant therapy) was recorded if available. Results: Eighteen studies were included in the review, of which 10 for soft tissue and 8 for bone. For soft tissue, defect-driven IOARM-studies showed the average accuracy, sensitivity, and specificity of 90.9%, 47.6%, and 84.4%, and specimen-driven IOARM-studies showed, 91.5%, 68.4%, and 96.7%, respectively. For bone, specimen-driven IOARM-studies performed better than defect-driven, with an average accuracy, sensitivity, and specificity of 96.6%, 81.8%, and 98%, respectively. For both, soft tissue and bone, IOARM positively impacts patient outcome. Conclusion: IOARM improves margin-status, especially the specimen-driven IOARM has higher performance compared to
- Published
- 2021
16. Screening for synchronous esophageal second primary tumors in patients with head and neck cancer
- Author
-
van de Ven, Steffi E.M., de Graaf, Wilmar, Bugter, Oisín, Spaander, Manon C.W., Nikkessen, Suzan, de Jonge, Pieter Jan F., Hardillo, Jose A., Sewnaik, Aniel, Monserez, Dominiek A., Mast, Hetty, Keereweer, Stijn, Bruno, Marco J., Baatenburg de Jong, Robert J., Koch, Arjun D., van de Ven, Steffi E.M., de Graaf, Wilmar, Bugter, Oisín, Spaander, Manon C.W., Nikkessen, Suzan, de Jonge, Pieter Jan F., Hardillo, Jose A., Sewnaik, Aniel, Monserez, Dominiek A., Mast, Hetty, Keereweer, Stijn, Bruno, Marco J., Baatenburg de Jong, Robert J., and Koch, Arjun D.
- Abstract
Patients with head and neck squamous cell carcinoma (HNSCC) have an increased risk of developing esophageal second primary tumors (ESPTs). We aimed to determine the incidence, stage, and outcome of synchronous ESPTs in patients with HNSCC in a Western population. We performed a prospective, observational, and cohort study. Patients diagnosed with HNSCC in the oropharynx, hypopharynx, any other sub-location in combination with alcohol abuse, or patients with two synchronous HNSCCs, between February 2019 and February 2020 underwent screening esophagogastroduodenoscopy (EGD). ESPT was defined as presence of esophageal squamous cell carcinoma (ESCC) or high grade dysplasia (HGD). Eighty-five patients were included. A lesion suspected for ESPT was detected in 14 of 85 patients, which was pathologically confirmed in five patients (1 ESCC and 4 HGD). The radiotherapy field was extended to the esophagus in two of five patients, HGD was treated with endoscopic resection in three of five patients. None of the ESPTs were detected on MRI and/or CT-scan prior to EGD. Of the remaining nine patients, three had low grade dysplasia on histology whereas the other six patients had benign lesions. Incidence of synchronous ESPT was 5.9% in our cohort of HNSCC patients. All ESPTs were diagnosed at an early stage and treated with curative intent. We recommend that screening for synchronous ESPTs should be considered in a selected group of patients with HNSCC.
- Published
- 2021
17. Malignant transformation of salivary gland pleomorphic adenoma:proof of principle
- Author
-
Valstar, Matthijs H., Mast, Hetty, ten Hove, Ivo, Moonen, Laura R., Balm, Alfons J.M., Smeele, Ludi E., Koljenović, Senada, Dinjens, Winand N.M., van Velthuysen, M.F. (Marie-Louise), Valstar, Matthijs H., Mast, Hetty, ten Hove, Ivo, Moonen, Laura R., Balm, Alfons J.M., Smeele, Ludi E., Koljenović, Senada, Dinjens, Winand N.M., and van Velthuysen, M.F. (Marie-Louise)
- Abstract
Supposed risk of malignant transformation of salivary gland pleomorphic adenoma (SGPA) is an important reason for aggressive retreatment in recurrent pleomorphic adenoma (RPA). However, although the diagnostic category ‘carcinoma ex-pleomorphic adenoma’ suggests that malignant transformation of a pleomorphic adenoma is a regular event, this has to date not been shown to occur in sequential lesions of one patient. Here, we show the molecular events in transformation to malignancy of a pleomorphic adenoma of the parotid gland. Detailed molecular analysis revealed an LIFR/PLAG1 translocation characteristic for pleomorphic adenoma and, next to this, a PIK3R1 frameshift mutation and several allelic imbalances. In subsequent malignant recurrences, the same LIFR/PLAG1 translocation, PIK3R1 frameshift mutation, and allelic imbalances were present in addition to TP53 mutations. Thus, this case not only shows malignant transformation of SGPA, but also demonstrates that molecular analysis can be of help in recognising malignancy in the rare instance of RPA.
- Published
- 2021
18. Performance of Intraoperative Assessment of Resection Margins in Oral Cancer Surgery: A Review of Literature
- Author
-
Barroso, Elisa M., primary, Aaboubout, Yassine, additional, van der Sar, Lisette C., additional, Mast, Hetty, additional, Sewnaik, Aniel, additional, Hardillo, Jose A., additional, ten Hove, Ivo, additional, Nunes Soares, Maria R., additional, Ottevanger, Lars, additional, Bakker Schut, Tom C., additional, Puppels, Gerwin J., additional, and Koljenović, Senada, additional
- Published
- 2021
- Full Text
- View/download PDF
19. Is the Depth of Invasion a Marker for Elective Neck Dissection in Early Oral Squamous Cell Carcinoma?
- Author
-
Aaboubout, Yassine, primary, van der Toom, Quincy M., additional, de Ridder, Maria A. J., additional, De Herdt, Maria J., additional, van der Steen, Berdine, additional, van Lanschot, Cornelia G. F., additional, Barroso, Elisa M., additional, Nunes Soares, Maria R., additional, ten Hove, Ivo, additional, Mast, Hetty, additional, Smits, Roeland W. H., additional, Sewnaik, Aniel, additional, Monserez, Dominiek A., additional, Keereweer, Stijn, additional, Caspers, Peter J., additional, Baatenburg de Jong, Robert J., additional, Bakker Schut, Tom C., additional, Puppels, Gerwin J., additional, Hardillo, José A., additional, and Koljenović, Senada, additional
- Published
- 2021
- Full Text
- View/download PDF
20. Intraoperative Assessment of the Resection Specimen Facilitates Achievement of Adequate Margins in Oral Carcinoma
- Author
-
Smits, Roeland, van Lanschot, Florence, Aaboubout, Yassine, de Ridder, Maria, Noordhoek Hegt, Vincent, Lamego Barroso, Elisa, Meeuwis, Cees, Sewnaik, A., Hardillo, Jose, Monserez, Dominiek, Keereweer, Stijn, Mast, Hetty, Hove, Ivo, Bakker Schut, Tom, Baatenburg de Jong, R.J., Puppels, Gerwin, Koljenovic, Senada, Smits, Roeland, van Lanschot, Florence, Aaboubout, Yassine, de Ridder, Maria, Noordhoek Hegt, Vincent, Lamego Barroso, Elisa, Meeuwis, Cees, Sewnaik, A., Hardillo, Jose, Monserez, Dominiek, Keereweer, Stijn, Mast, Hetty, Hove, Ivo, Bakker Schut, Tom, Baatenburg de Jong, R.J., Puppels, Gerwin, and Koljenovic, Senada
- Published
- 2020
21. Intraoperative Assessment of the Resection Specimen Facilitates Achievement of Adequate Margins in Oral Carcinoma
- Author
-
Smits, Roeland W. H., primary, van Lanschot, Cornelia G. F., additional, Aaboubout, Yassine, additional, de Ridder, Maria, additional, Hegt, Vincent Noordhoek, additional, Barroso, Elisa M., additional, Meeuwis, Cees A., additional, Sewnaik, Aniel, additional, Hardillo, Jose A., additional, Monserez, Dominiek, additional, Keereweer, Stijn, additional, Mast, Hetty, additional, Hove, Ivo Ten, additional, Bakker Schut, Tom C., additional, Baatenburg de Jong, Robert J., additional, Puppels, Gerwin J., additional, and Koljenović, Senada, additional
- Published
- 2020
- Full Text
- View/download PDF
22. Long-term outcomes following stereotactic body radiotherapy boost for oropharyngeal squamous cell carcinoma
- Author
-
Baker, Sarah, Verduijn, Gerda, Petit, Steven, Sewnaik, A., Mast, Hetty, Koljenovic, Senada, Nuyttens, J.J.M.E., Heemsbergen, Wilma, Baker, Sarah, Verduijn, Gerda, Petit, Steven, Sewnaik, A., Mast, Hetty, Koljenovic, Senada, Nuyttens, J.J.M.E., and Heemsbergen, Wilma
- Published
- 2019
23. Relocation of inadequate resection margins in the wound bed during oral cavity oncological surgery: A feasibility study
- Author
-
van Lanschot, Florence, Mast, Hetty, Hardillo, Jose, Monserez, Dominiek, Hove, Ivo, Lamego Barroso, Elisa, Cals, F, Smits, Roeland, van der Kamp, MF, Meeuwis, Cees, Sewnaik, A., Verdijk, Rob, van Leenders, Arno, Noordhoek Hegt, Vincent, Bakker Schut, Tom, Baatenburg de Jong, R.J., Puppels, Gerwin, Koljenovic, Senada, van Lanschot, Florence, Mast, Hetty, Hardillo, Jose, Monserez, Dominiek, Hove, Ivo, Lamego Barroso, Elisa, Cals, F, Smits, Roeland, van der Kamp, MF, Meeuwis, Cees, Sewnaik, A., Verdijk, Rob, van Leenders, Arno, Noordhoek Hegt, Vincent, Bakker Schut, Tom, Baatenburg de Jong, R.J., Puppels, Gerwin, and Koljenovic, Senada
- Published
- 2019
24. Water Concentration Analysis by Raman Spectroscopy to Determine the Location of the Tumor Border in Oral Cancer Surgery
- Author
-
Barroso, Elisa M., primary, Smits, Roeland W.H., additional, van Lanschot, Cornelia G.F., additional, Caspers, Peter J., additional, ten Hove, Ivo, additional, Mast, Hetty, additional, Sewnaik, Aniel, additional, Hardillo, José A., additional, Meeuwis, Cees A., additional, Verdijk, Rob, additional, Noordhoek Hegt, Vincent, additional, Baatenburg de Jong, Robert J., additional, Wolvius, Eppo B., additional, Bakker Schut, Tom C., additional, Koljenović, Senada, additional, and Puppels, Gerwin J., additional
- Published
- 2016
- Full Text
- View/download PDF
25. Development of an Ex Vivo Functional Assay for Prediction of Irradiation Related Toxicity in Healthy Oral Mucosa Tissue.
- Author
-
Pachler KS, Lauwers I, Verkaik NS, Rovituso M, van der Wal E, Mast H, Jonker BP, Sewnaik A, Hardillo JA, Keereweer S, Monserez D, Kremer B, Koppes S, van den Bosch TPP, Verduijn GM, Petit S, Sørensen BS, van Gent DC, and Capala ME
- Subjects
- Humans, X-Rays adverse effects, Radiation Injuries etiology, Radiation Injuries pathology, Male, Mucositis etiology, Mucositis pathology, Female, Dose-Response Relationship, Radiation, Stomatitis etiology, Stomatitis pathology, Adult, Middle Aged, Mouth Mucosa radiation effects
- Abstract
Radiotherapy in the head-and-neck area is one of the main curative treatment options. However, this comes at the cost of varying levels of normal tissue toxicity, affecting up to 80% of patients. Mucositis can cause pain, weight loss and treatment delays, leading to worse outcomes and a decreased quality of life. Therefore, there is an urgent need for an approach to predicting normal mucosal responses in patients prior to treatment. We here describe an assay to detect irradiation responses in healthy oral mucosa tissue. Mucosa specimens from the oral cavity were obtained after surgical resection, cut into thin slices, irradiated and cultured for three days. Seven samples were irradiated with X-ray, and three additional samples were irradiated with both X-ray and protons. Healthy oral mucosa tissue slices maintained normal morphology and viability for three days. We measured a dose-dependent response to X-ray irradiation and compared X-ray and proton irradiation in the same mucosa sample using standardized automated image analysis. Furthermore, increased levels of inflammation-inducing factors-major drivers of mucositis development-could be detected after irradiation. This model can be utilized for investigating mechanistic aspects of mucositis development and can be developed into an assay to predict radiation-induced toxicity in normal mucosa.
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.